Filter Results
:
(326)
Show Results For
-
All HBS Web
(326)
- News (80)
- Research (181)
- Events (1)
- Multimedia (3)
- Faculty Publications (45)
Show Results For
-
All HBS Web
(326)
- News (80)
- Research (181)
- Events (1)
- Multimedia (3)
- Faculty Publications (45)
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that patients in the West can now...
View Details
Keywords:
by Julie Jette
Stanley P. Goldstein
establishments into an industry-focused healthcare company under the CVS name. His restructuring gamble paid off – building the largest drug retail chain in the United States generating over $15 billion in...
View Details
Keywords:
Retail
- 01 Dec 2019
- News
The Race Against Resistance
tide. “If we don’t take steps to slow down or stop drug resistance, we will fall back to a time when simple infections killed people. Can you imagine? That’s a bit of a doomsday perspective, but it’s a call to action.” “We are approaching...
View Details
Keywords:
Lisa Scanlon Mogolov
- 01 Jun 2000
- News
The Business of Biotech
December). Amgen's Epogen (a treatment for anemia in kidney dialysis patients) and Neupogen (which restores white blood cells in cancer patients) generated more than $2 billion in sales last year. As the ability to analyze a patient's...
View Details
Keywords:
Julia Hanna
- 01 Jun 2001
- News
Stephen M. Moret: A Campaign for Positive Change
low-cost HIV/AIDS drugs to Malawi. “I’m the guy who still can’t believe I got to go to school here.” After traveling around the world this fall, Moret will take a position in McKinsey’s Washington, D.C., office, where he hopes to spend...
View Details
- Web
Financial Aid - HBS Fund Investors Society 2021 Report
Financial Aid Financial Aid From Scholarships to Life-Saving Impact Nora Rabah (MS/MBA 2022), who emigrated to the United States as a child, remembers the hardship of growing up without health care and wants to make drugs for children...
View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
cells in cancer patients) generated more than $2 billion in sales last year. Millennium Pharmaceuticals: Alan Crane (photo: Shelly R. Harrison) As the ability to analyze a patient's genetic material is developed, however, many believe...
View Details
- 27 Jun 2005
- Research & Ideas
The Potential Downside of Win-Win
little effect on the restaurant or movie industry. Their contentment left society slightly better off. It is generally wonderful when parties are able to trade off interests to create value. In fact, one of the most important...
View Details
Keywords:
by Max H. Bazerman
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
Cambridge, Massachusetts, and you will likely be administered beta blockers, a class of drug that's generally recommended after a heart attack. The rate at which that drug is...
View Details
- 09 Aug 2016
- First Look
August 9, 2016
spending in the United States, accounting for less than 1% of prescriptions filled but nearly 28% of drug spending. Whereas traditional (chemically synthesized, "small-molecule") drugs have...
View Details
Keywords:
Sean Silverthorne
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
economic development of host countries and what is the role of local financial markets in mediating the potential benefits? We first define FDI and discuss general theories on types and drivers of FDI. This review takes a host-country...
View Details
Keywords:
Sean Silverthorne
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
wants to understand the barriers to effecting change on global issues such as health care." Under Ray Gilmartin's leadership, Merck has launched an unprecedented number of new drugs and forged partnerships with the public and nonprofit...
View Details
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that manufactures and sells...
View Details
- 20 Aug 2014
- News
With No Time to Lose
into ALS research, and removed some critical barriers to the development of treatments. “Our focus, from the start, was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed with the disease in 2004, just weeks...
View Details
Keywords:
Margie Kelley
- 01 Jun 2010
- News
$how Me the Money
Bank made a $160 million settlement with the Justice Department, agreeing it had been lax about accepting drug money from Mexico.) While U.S. law is tough on drug trafficking, terrorist financing, bank...
View Details
Keywords:
Garry Emmons;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support
- 18 Sep 2014
- News
Room to grow: global expansion in the middle ground
consulting firm Shaldor, documents the specific strategies various companies pursued. As examples, by focusing on a neglected market segment, Netafim became the world leader in drip irrigation technology, while Teva Pharmaceutical created a scalable, acquisition-based...
View Details
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
drugs (chemically-synthesized, “small-molecule” drugs) face price competition from generic drugs after patent expiration, biosimilars—biologic View Details
Keywords:
Sean Silverthorne
- Web
2.3.5 Research Misconduct - MBA
2.3 Community Standards of Conduct 2.3.5 Research Misconduct Welcome to HBS Being a Student at HBS 1. Academic Information & Policies 2. Integrity & Standards of Conduct 2.1 Academic Standards of Conduct 2.2 Recruiting Standards of Conduct 2.3 Community Standards of...
View Details
- Web
2.3.7 Physical Violence - MBA
2.3 Community Standards of Conduct 2.3.7 Physical Violence Welcome to HBS Being a Student at HBS 1. Academic Information & Policies 2. Integrity & Standards of Conduct 2.1 Academic Standards of Conduct 2.2 Recruiting Standards of Conduct 2.3 Community Standards of...
View Details
- 29 Jun 2022
- Blog Post
Harvard Business School Announces the 2022-2023 Blavatnik Fellows
and fellows’ companies funding has quadrupled. It is gratifying to be a part of the program’s tremendous growth and mentor next generation entrepreneurs who contribute to society by commercializing groundbreaking technology and biomedical...
View Details